Home » FDA WARNS BIOMARIN ABOUT ORAPRED CLAIMS
FDA WARNS BIOMARIN ABOUT ORAPRED CLAIMS
Federal health officials sent a warning letter to BioMarin Pharmaceutical Inc. Wednesday, saying a company Web site makes unsubstantiated claims for the liquid form of the drug Orapred, a steroid used to reduce inflammation in asthma and other conditions.
MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20061012&ID=6099052)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct